STOCK TITAN

STERIS director Mohsen Sohi sells 4,893 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

STERIS plc director Mohsen Sohi exercised a fully vested option on November 10, 2026, to acquire 4,893 ordinary shares at an exercise price of $114.74 per share. Sohi sold 3,228 shares at a weighted average of $252.87 and 1,665 shares at a weighted average of $253.90 that day; the respective sale-price ranges were $252.66–$253.43 and $253.69–$254.31. No Rule 10b5-1 plan is reported.

Insider Sohi Mohsen
Role Director
Sold 4,893 shs ($1.24M)
Approx. gross sale proceeds $1.24M
Approx. exercise cost $561K
Approx. pre-tax spread $678K
Type Security Shares Price Value
Exercise Director Stock Option (right to buy) F3 4,893 $0.00 $0.00
Exercise Ordinary Shares 4,893 $114.74 $561K
Sale Ordinary Shares F1 3,228 $252.87 $816K
Sale Ordinary Shares F2 1,665 $253.90 $423K
Holdings After Transaction: Director Stock Option (right to buy) — 0 options (Direct); Ordinary Shares — 24,305 shares (Direct)
Footnotes (3)
  1. F1. Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. F2. Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. F3. This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Option exercised 4,893 options Exercise on November 10, 2026
Exercise price $114.74 per share Option exercise on November 10, 2026
Shares sold, first transaction 3,228 shares November 10, 2026; weighted average sale price $252.87 per share
Weighted average sale price, first transaction $252.87 per share Transactions ranged from $252.66 to $253.43
Shares sold, second transaction 1,665 shares November 10, 2026; weighted average sale price $253.90 per share
Weighted average sale price, second transaction $253.90 per share Transactions ranged from $253.69 to $254.31
weighted average sale price financial
"Price reflects a weighted average sale price for multiple transactions"
redomiciliation technical
"redomiciliation of STERIS plc to Ireland"
Redomiciliation is when a company legally changes its country of incorporation while keeping the same business and assets, like moving a house to a new neighborhood but keeping the same furniture. Investors care because the company then follows a different set of laws and tax rules, which can change shareholder rights, reporting standards, dividend treatment and the ease of trading the stock, potentially affecting risk and return.
fully vested financial
"which is fully vested"
exercise price financial
"for $114.74 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STE shares did director Mohsen Sohi sell, and at what prices?

On November 10, 2026, Mohsen Sohi sold 3,228 STERIS ordinary shares at a weighted average of $252.87, with transactions ranging from $252.66 to $253.43, and 1,665 shares at a weighted average of $253.90, ranging from $253.69 to $254.31.

What option did Mohsen Sohi exercise in STE?

Mohsen Sohi exercised a fully vested option to purchase 4,893 STERIS ordinary shares at $114.74 per share on November 10, 2026. The option was received in connection with STERIS plc’s March 2019 redomiciliation to Ireland, in exchange for an option to purchase Old STERIS shares under the same terms and conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sohi Mohsen

(Last)(First)(Middle)
70 SIR JOHN ROGERSON'S QUAY

(Street)
DUBLIN 2D02 R296

(City)(State)(Zip)

IRELAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/10/2026M4,893A$114.7429,198D
Ordinary Shares11/10/2026S3,228D$252.87(1)25,970D
Ordinary Shares11/10/2026S1,665D$253.9(2)24,305D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Stock Option (right to buy)$114.7411/10/2026M4,893 (3)08/09/2028Ordinary Shares4,893$00D
Explanation of Responses:
1. Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
2. Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3. This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading